A small selection of relevant peer-reviewed publications
Burokas, A. et al. (2017) “Targeting the Microbiota-Gut-Brain Axis: Prebiotics Have Anxiolytic and Antidepressant-like Effects and Reverse the Impact of Chronic Stress in Mice,” Biological Psychiatry, 82(7), pp. 472–487. doi: 10.1016/j.biopsych.2016.12.031.
Caputi, V. and Giron, M. (2018) “Microbiome-Gut-Brain Axis and Toll-Like Receptors in Parkinson’s Disease,” International Journal of Molecular Sciences, 19(6), p. 1689. doi: 10.3390/ijms19061689.
Carlson, A. L. et al. (2018a) “Infant Gut Microbiome Associated With Cognitive Development,” Biological Psychiatry, 83(2), pp. 148–159. doi: 10.1016/j.biopsych.2017.06.021.
Castaner, O. et al. (2018) “The Gut Microbiome Profile in Obesity: A Systematic Review,” International Journal of Endocrinology, 2018, pp. 1–9. doi: 10.1155/2018/4095789.
De Luca, F. and Shoenfeld, Y. (2018) “The microbiome in autoimmune diseases,” Clinical & Experimental Immunology, 195(1), pp. 74–85. doi: 10.1111/cei.13158.
Kelly, J. R. et al. (2016) “Transferring the blues: Depression-associated gut microbiota induces neurobehavioural changes in the rat,” Journal of Psychiatric Research, 82, pp. 109–118. doi: 10.1016/j.jpsychires.2016.07.019.
Lach, G. et al. (2017) “Anxiety, Depression, and the Microbiome: A Role for Gut Peptides,” Neurotherapeutics, 15(1), pp. 36–59. doi: 10.1007/s13311-017-0585-0.
Marrs, T. and Sim, K. (2018) “Demystifying Dysbiosis: Can the Gut Microbiome Promote Oral Tolerance Over IgE-mediated Food Allergy?,” Current Pediatric Reviews, 14(3), pp. 156–163. doi: 10.2174/1573396314666180507120424.
Moser, G., Fournier, C. and Peter, J. (2017) “Intestinal microbiome-gut-brain axis and irritable bowel syndrome,” Wiener Medizinische Wochenschrift, 168(3–4), pp. 62–66. doi: 10.1007/s10354-017-0592-0.
Murugesan, S. et al. (2017) “Gut microbiome production of short-chain fatty acids and obesity in children,” European Journal of Clinical Microbiology & Infectious Diseases, 37(4), pp. 621–625. doi: 10.1007/s10096-017-3143-0.
“OP017. Multi-donor intense faecal microbiota transplantation is an effective treatment for resistant ulcerative colitis: a randomised placebo-controlled trial” (2016) Journal of Crohn’s and Colitis, 10(suppl 1), p. S14.1-S14. doi: 10.1093/ecco-jcc/jjw019.016.
Pröbstel, A.-K. and Baranzini, S. E. (2017) “The Role of the Gut Microbiome in Multiple Sclerosis Risk and Progression: Towards Characterization of the ‘MS Microbiome,’” Neurotherapeutics, 15(1), pp. 126–134. doi: 10.1007/s13311-017-0587-y.
Sochocka, M. et al. (2018) “The Gut Microbiome Alterations and Inflammation-Driven Pathogenesis of Alzheimer’s Disease—a Critical Review,” Molecular Neurobiology, 56(3), pp. 1841–1851. doi: 10.1007/s12035-018-1188-4.
Stokholm, J. et al. (2018) “Maturation of the gut microbiome and risk of asthma in childhood,” Nature Communications, 9(1). doi: 10.1038/s41467-017-02573-2.
Ticinesi, A. et al. (2018) “Gut microbiota, cognitive frailty and dementia in older individuals: a systematic review,” Clinical Interventions in Aging, Volume 13, pp. 1497–1511. doi: 10.2147/cia.s139163.
Yang, Y., Tian, J. and Yang, B. (2018) “Targeting gut microbiome: A novel and potential therapy for autism,” Life Sciences, 194, pp. 111–119. doi: 10.1016/j.lfs.2017.12.027.